This report contains market size and forecasts of Translational Regenerative Medicine in global, including the following market information:
Global Translational Regenerative Medicine Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Translational Regenerative Medicine Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Translational Regenerative Medicine companies in 2021 (%)
The global Translational Regenerative Medicine market was valued at 12590 million in 2021 and is projected to reach US$ 29460 million by 2028, at a CAGR of 12.9% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Stem Cell Therapy Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Translational Regenerative Medicine include Athersys, Avita Medical, AxoGen, MEDIPOST, NuVasive, Astellas Pharma, Organogenesis Holdings, Osiris Therapeutics and Pharmicell, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Translational Regenerative Medicine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Translational Regenerative Medicine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Translational Regenerative Medicine Market Segment Percentages, by Type, 2021 (%)
Stem Cell Therapy
Tissue Engineering
Gene Therapy
Global Translational Regenerative Medicine Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Translational Regenerative Medicine Market Segment Percentages, by Application, 2021 (%)
Tissue Engineering Therapy
Wound Healing
Cartilage Repair
Other
Global Translational Regenerative Medicine Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Translational Regenerative Medicine Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Translational Regenerative Medicine revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Translational Regenerative Medicine revenues share in global market, 2021 (%)
Key companies Translational Regenerative Medicine sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Translational Regenerative Medicine sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Athersys
Avita Medical
AxoGen
MEDIPOST
NuVasive
Astellas Pharma
Organogenesis Holdings
Osiris Therapeutics
Pharmicell
Regenerys
Takeda Pharmaceutical
uniQure
Vericel